Multiple myeloma: understanding the impact of the disease
Clinical Previous     Next

Multiple myeloma: understanding the impact of the disease

Patricia Jean Smith Research fellow, Department of Applied Biological Sciences, City University, St Bartholomew School of Nursing and Midwifery, London
Carol Lynn Cox Acting deputy director, Institute of Health Sciences, City University, St Bartholomew School of Nursing and Midwifery, London
Daniel Kelly Reader in cancer and palliative care, Middlesex University, London

Multiple myeloma is a cancer of the red bone marrow and despite modern treatments, such as high dose chemotherapy and stem cell transplants, it remains incurable with a median survival of between three to four years (Hoffbrand et al 2001, Bradwell 2003). The aim of this article is to increase awareness and understanding of this relatively unknown cancer.

Cancer Nursing Practice. 6, 1,25-28. doi: 10.7748/cnp2007.02.6.1.25.c4189

You need a subscription to read the full article